Quick answer: Sermorelin is a synthetic peptide that copies the first 29 amino acids of human growth hormone releasing hormone, the signal the hypothalamus normally sends to the pituitary gland. Sermorelin does not supply growth hormone from outside the body; sermorelin asks the pituitary to release the growth hormone it already makes. Because the signal acts upstream of the gland, the body's own feedback controls stay in the loop and limit how far a single pulse can go. Compounded sermorelin is not FDA-approved, and it is prescribed only when a licensed clinician reviews your history and labs and judges treatment appropriate.
Sermorelin is best understood as a message rather than a substance you are topping up. Growth hormone releasing hormone is the natural molecule your hypothalamus uses to tell the pituitary to let go of a pulse of growth hormone, and sermorelin is the shortest fragment of it that still activates the same receptor. Nothing about sermorelin adds hormone to your bloodstream directly, which is the fact that explains most of what follows.
What sermorelin is, chemically
Sermorelin is a chain of 29 amino acids corresponding to residues 1 through 29 of human growth hormone releasing hormone. That fragment retains full biological activity at the GHRH receptor, so the rest of the natural sequence is not required. Calling sermorelin an analog rather than a copy is accurate, because shortening the molecule changes how quickly the body clears it.
Sermorelin is a peptide, not a steroid and not a conventional small molecule drug. Chemistry here dictates practical things such as route of administration and how long the molecule survives once it is inside you.
Sermorelin has a short half-life, commonly cited in published pharmacology as roughly ten to twenty minutes after subcutaneous administration. Brevity is deliberate rather than a defect, since a short signal produces a pulse and then clears, leaving the axis free to settle back toward baseline. Longer acting GHRH analogs exist and behave quite differently, which is why comparisons across the category rarely translate cleanly.
How the signal travels through the GH/IGF-1 axis
The GH/IGF-1 axis is the chain running from hypothalamus to pituitary to liver. Your hypothalamus releases growth hormone releasing hormone, your pituitary responds by releasing growth hormone, and your liver responds to that by producing insulin-like growth factor 1. Most of what adults associate with growth hormone is actually mediated by IGF-1 rather than by growth hormone acting on tissue directly.
Sermorelin acts on receptors located on the somatotroph cells of the pituitary gland, the small structure at the base of the brain that stores and releases growth hormone. Stimulating those receptors produces a burst of hormone rather than a steady drip, so sermorelin depends on a pituitary still capable of producing growth hormone.
Feedback is the part of the system people tend to skip. Rising growth hormone and IGF-1 increase somatostatin, the hypothalamic hormone that inhibits further growth hormone release, so the axis restrains itself. Preserved feedback is a real structural difference from direct hormone administration, but it is not a safety promise and it does not remove the need for clinical monitoring and periodic labs.
Secretagogue versus replacement
A secretagogue is any substance that causes a gland to secrete something it already produces, rather than supplying that substance from outside. Sermorelin is a growth hormone secretagogue in exactly that sense. Distinguishing the two approaches is not marketing language, because they sit in different regulatory categories, carry different monitoring expectations, and place different ceilings on how much hormone can end up circulating.
Synthetic human growth hormone sits at the opposite end of the chain, delivering the finished hormone straight into circulation and bypassing the pituitary entirely. Prescribing rules for synthetic growth hormone in the United States are narrow and specific for that reason. If the distinction matters to you, the longer treatment of it lives in our comparison of how sermorelin and synthetic HGH differ mechanically.
Why sermorelin is injected rather than swallowed
Sermorelin is injected because peptides taken by mouth are broken down by stomach acid and digestive proteases before meaningful amounts reach the bloodstream. Subcutaneous injection places the peptide into tissue where absorption into circulation is direct and reasonably predictable. Skepticism is warranted toward oral, sublingual, and nasal peptide products marketed for the same purpose, since published human bioavailability data supporting equivalence is generally missing.
Timing is the other practical consideration, and it follows from the biology rather than from convenience. Your own largest growth hormone pulse normally arrives shortly after sleep onset, which is why the signal is usually aligned with that window and separated from food. Specific timing is set by the prescribing clinician for the individual, and we go deeper into the reasoning in our piece on why sleep is where people notice something first.
What the human evidence actually shows
Human evidence for sermorelin is real but narrower than most marketing implies. Sermorelin has been studied in people, historically as a diagnostic agent for growth hormone deficiency and in pediatric growth indications, and GHRH administration has been examined in small adult trials including work on sleep and cognition. Large, long-duration randomized trials in healthy middle-aged adults are largely absent.
Much of what circulates online about peptides more broadly comes from animal or cell-culture work. Preclinical findings describe what happened in a dish or a rodent, and they do not reliably predict what happens in a middle-aged man. Anyone presenting animal data as though it settles a human question is overselling.
Frequently Asked Questions
Is sermorelin the same as growth hormone?
Sermorelin is not growth hormone. Sermorelin is an analog of the hormone that tells the pituitary gland to release growth hormone, so the hormone that reaches your bloodstream is your own. Growth hormone therapy, by contrast, delivers the finished hormone directly.
Is compounded sermorelin FDA-approved?
Compounded sermorelin is not FDA-approved. A branded sermorelin product was approved in the United States years ago and later withdrawn from the market for commercial reasons, and the preparations available today are made by licensed compounding pharmacies rather than approved by the agency. Anyone claiming FDA approval for compounded sermorelin is wrong.
Does sermorelin shut down your own production?
Suppression is the concern raised with exogenous hormone, where circulating hormone from outside signals the gland to stand down. Sermorelin works in the opposite direction by stimulating the pituitary, and current understanding is that it does not cause that kind of shutdown. Long-term human data in healthy aging adults remains limited, so calling the question fully settled would overstate what is known.
How is sermorelin different from ipamorelin or CJC-1295?
Sermorelin and CJC-1295 both act at the GHRH receptor, with CJC-1295 engineered for a considerably longer duration of action, while ipamorelin reaches growth hormone release through the ghrelin receptor instead. Human clinical data varies widely in quantity and quality across the three. Which, if any, is appropriate is a prescribing decision rather than a menu choice.
Do you need a prescription for sermorelin?
Sermorelin is a prescription medication in the United States, so a licensed clinician must evaluate you before anything is dispensed. Evaluation covers medical history, current medications, symptoms, and appropriate lab work including baseline IGF-1. Certain histories, including active or prior malignancy, are standard reasons a clinician declines, as covered in our guide to who should not take sermorelin.
The honest summary
Sermorelin is a well-characterized molecule with a clean, plausible mechanism: a short GHRH fragment that prompts your own pituitary to pulse, inside a feedback system that stays intact. Mechanism is the strongest part of the case, and it is fair to find it convincing on those terms. What mechanism cannot do is tell you how you personally will respond.
Honesty about the limits is the point. Compounded sermorelin is not FDA-approved, the human trial base in healthy middle-aged adults is thin, and results differ from person to person for reasons nobody can predict in advance. Restoration rather than transcendence is the accurate framing, and a clinician who is willing to tell you no is worth more than one who promises anything. Growth hormone output falls measurably with adult age, a pattern covered in what actually happens to growth hormone as you get older.
References
Primary sources for the claims above. Where a study is preclinical, that is stated in the section it supports.
Growth hormone responses to growth hormone-releasing hormone (1-29)-NH2 and a D-Ala2 analog in normal men. Peptides. 1985. PMID 2866496.
Growth hormone releasing hormone. Clinics in endocrinology and metabolism. 1986. PMID 2429796.
Growth hormone secretion in the elderly: ageing and the somatopause. Bailliere's clinical endocrinology and metabolism. 1997. PMID 9403121.
Growth hormone releasing hormone in the assessment and long-term treatment of growth hormone deficiency. Acta paediatrica Scandinavica. Supplement. 1987. PMID 3111168.
Compounded medications are not FDA-approved and are not the same as, nor a substitute for, FDA-approved products. Prescription products require an evaluation by a licensed provider who determines whether a prescription is appropriate. A prescription is not guaranteed. Individual results vary. Everhuman does not provide medical advice; clinical care is delivered by Arora Health.